Cargando…

Metabolic syndrome related to cardiovascular events in a 10-year prospective study

BACKGROUND: Metabolic syndrome (MetS) becomes a serious society health problem. The main risk factors of MetS are related to the increased risk of cardiovascular diseases, appearance of stroke, type 2 diabetes mellitus and the growing risk of mortality. MetS stimulates the appearance of early athero...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazlauskienė, Laura, Butnorienė, Jūratė, Norkus, Antanas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653909/
https://www.ncbi.nlm.nih.gov/pubmed/26594246
http://dx.doi.org/10.1186/s13098-015-0096-2
_version_ 1782401999340306432
author Kazlauskienė, Laura
Butnorienė, Jūratė
Norkus, Antanas
author_facet Kazlauskienė, Laura
Butnorienė, Jūratė
Norkus, Antanas
author_sort Kazlauskienė, Laura
collection PubMed
description BACKGROUND: Metabolic syndrome (MetS) becomes a serious society health problem. The main risk factors of MetS are related to the increased risk of cardiovascular diseases, appearance of stroke, type 2 diabetes mellitus and the growing risk of mortality. MetS stimulates the appearance of early atherosclerosis, its progress and accelerates the frequency of cardiovascular complications related to atherosclerosis and diabetes mellitus. OBJECTIVE: To evaluate the risk of cardiovascular events (myocardial infarction, stroke) among the individuals with MetS in a 10 year prospective study; to identify MetS components that determine risk and character of cardiovascular events. METHODS: The study design was prospective. It was started in 2003 to assess the risk factors, clinical components, diagnostic criteria of MetS. At the second stage in 2013 the individuals were repeatedly invited to evaluate cardiovascular pathology that was confirmed by cardiologist and neurologist. The 45 years old and older citizens of Lithuanian district participated in the study. 1115 individuals (562 men and 553 women) were randomly selected in 2003. 538 respondents: 278 (51.70 %) men and 260 (48.30 %) women participated in the repeated study in 2013. RESULTS: During the study myocardial infarction (MI) was confirmed to 7.43 % individuals taken part in the study, stroke—to 4.28 % individuals. The odds’ ratio (OR) of MI between individuals with MetS and without MetS was 1.80 (95 % CI 1.67–1.97), p < 0.05. The OR of stroke for individuals with MetS and without MetS was 2.05 (95 % CI 1.21–2.54), p < 0.05. The OR of MI between men with abdominal obesity and identified MetS was 3.12 (95 % CI 2.77–3.53), p < 0.05. The OR of stroke between men with low level of high density lipoprotein cholesterol and identified MetS was 4.98 (95 % CI 4.40–5.65), p < 0.05. The OR of stroke between men with hypertriglyceridemia and identified MetS was 8.43 (95 % CI 7.45–9.54), p < 0.05. CONCLUSIONS: Individuals with identified MetS have 1.80 and 2.05 times higher statistically significant probability, respectively, for MI and stroke events, than individuals without MetS. Separate components or MetS increase risk of cardiovascular events in men: abdominal obesity increases risk of MI, and low level of high density lipoprotein cholesterol and hypertriglyceridemia increase risk of stroke.
format Online
Article
Text
id pubmed-4653909
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46539092015-11-21 Metabolic syndrome related to cardiovascular events in a 10-year prospective study Kazlauskienė, Laura Butnorienė, Jūratė Norkus, Antanas Diabetol Metab Syndr Research BACKGROUND: Metabolic syndrome (MetS) becomes a serious society health problem. The main risk factors of MetS are related to the increased risk of cardiovascular diseases, appearance of stroke, type 2 diabetes mellitus and the growing risk of mortality. MetS stimulates the appearance of early atherosclerosis, its progress and accelerates the frequency of cardiovascular complications related to atherosclerosis and diabetes mellitus. OBJECTIVE: To evaluate the risk of cardiovascular events (myocardial infarction, stroke) among the individuals with MetS in a 10 year prospective study; to identify MetS components that determine risk and character of cardiovascular events. METHODS: The study design was prospective. It was started in 2003 to assess the risk factors, clinical components, diagnostic criteria of MetS. At the second stage in 2013 the individuals were repeatedly invited to evaluate cardiovascular pathology that was confirmed by cardiologist and neurologist. The 45 years old and older citizens of Lithuanian district participated in the study. 1115 individuals (562 men and 553 women) were randomly selected in 2003. 538 respondents: 278 (51.70 %) men and 260 (48.30 %) women participated in the repeated study in 2013. RESULTS: During the study myocardial infarction (MI) was confirmed to 7.43 % individuals taken part in the study, stroke—to 4.28 % individuals. The odds’ ratio (OR) of MI between individuals with MetS and without MetS was 1.80 (95 % CI 1.67–1.97), p < 0.05. The OR of stroke for individuals with MetS and without MetS was 2.05 (95 % CI 1.21–2.54), p < 0.05. The OR of MI between men with abdominal obesity and identified MetS was 3.12 (95 % CI 2.77–3.53), p < 0.05. The OR of stroke between men with low level of high density lipoprotein cholesterol and identified MetS was 4.98 (95 % CI 4.40–5.65), p < 0.05. The OR of stroke between men with hypertriglyceridemia and identified MetS was 8.43 (95 % CI 7.45–9.54), p < 0.05. CONCLUSIONS: Individuals with identified MetS have 1.80 and 2.05 times higher statistically significant probability, respectively, for MI and stroke events, than individuals without MetS. Separate components or MetS increase risk of cardiovascular events in men: abdominal obesity increases risk of MI, and low level of high density lipoprotein cholesterol and hypertriglyceridemia increase risk of stroke. BioMed Central 2015-11-19 /pmc/articles/PMC4653909/ /pubmed/26594246 http://dx.doi.org/10.1186/s13098-015-0096-2 Text en © Kazlauskienė et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kazlauskienė, Laura
Butnorienė, Jūratė
Norkus, Antanas
Metabolic syndrome related to cardiovascular events in a 10-year prospective study
title Metabolic syndrome related to cardiovascular events in a 10-year prospective study
title_full Metabolic syndrome related to cardiovascular events in a 10-year prospective study
title_fullStr Metabolic syndrome related to cardiovascular events in a 10-year prospective study
title_full_unstemmed Metabolic syndrome related to cardiovascular events in a 10-year prospective study
title_short Metabolic syndrome related to cardiovascular events in a 10-year prospective study
title_sort metabolic syndrome related to cardiovascular events in a 10-year prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653909/
https://www.ncbi.nlm.nih.gov/pubmed/26594246
http://dx.doi.org/10.1186/s13098-015-0096-2
work_keys_str_mv AT kazlauskienelaura metabolicsyndromerelatedtocardiovasculareventsina10yearprospectivestudy
AT butnorienejurate metabolicsyndromerelatedtocardiovasculareventsina10yearprospectivestudy
AT norkusantanas metabolicsyndromerelatedtocardiovasculareventsina10yearprospectivestudy